Finance

Beta
Lists
ELOX:NASDAQ
Eloxx Pharmaceuticals Inc
$6.20
0.00%
(0.00) 1D
Jun 5, 1:06:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELOX...
Mkt. cap
7.57M
Avg. vol.
654.00
Volume
134.00
52-wk high
$10.00
52-wk low
$1.11
Beta
4.96
Shares outstanding
461.00K
No. of employees
10
Mkt. cap
7.57M
Avg. vol.
654.00
Volume
134.00
52-wk high
$10.00
52-wk low
$1.11
Beta
4.96
Shares outstanding
461.00K
No. of employees
10
News stories
From sources across the web
About Eloxx Pharmaceuticals Inc
CEO-
Employees10
Founded1999
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeloxxpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2023
Dec 2023
Mar 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
510.00K
1.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
712.00K
2.14M
Operating expense
-
-
1.22M
3.80M
Total operating expenses
-
-
1.22M
3.80M
Operating income
-
-
-1.22M
-3.80M
Other non operating income
-
-
-9.00K
-9.00K
EBT including unusual items
-
-
-1.71M
-3.75M
EBT excluding unusual items
-
-
-1.71M
-3.81M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-1.71M
-3.75M
Net profit margin
-
-
-
-
Earnings per share
-14.41
-
-
-
Interest and investment income
-
-
5.00K
23.00K
Interest expense
-
-
-483.00K
-29.00K
Net interest expenses
-
-
-478.00K
-6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-1.21M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer